309 related articles for article (PubMed ID: 29262821)
1. Assessment of a bedside test for N-terminal pro B-type natriuretic peptide (NT-proBNP) to differentiate cardiac from non-cardiac causes of pleural effusion in cats.
Wurtinger G; Henrich E; Hildebrandt N; Wiedemann N; Schneider M; Hassdenteufel E
BMC Vet Res; 2017 Dec; 13(1):394. PubMed ID: 29262821
[TBL] [Abstract][Full Text] [Related]
2. Differentiation of Cardiac from Noncardiac Pleural Effusions in Cats using Second-Generation Quantitative and Point-of-Care NT-proBNP Measurements.
Hezzell MJ; Rush JE; Humm K; Rozanski EA; Sargent J; Connolly DJ; Boswood A; Oyama MA
J Vet Intern Med; 2016; 30(2):536-42. PubMed ID: 26813037
[TBL] [Abstract][Full Text] [Related]
3. Assessment of circulating N-terminal pro B-type natriuretic peptide concentration to differentiate between cardiac from noncardiac causes of pleural effusion in cats.
Hassdenteufel E; Henrich E; Hildebrandt N; Stosic A; Schneider M
J Vet Emerg Crit Care (San Antonio); 2013; 23(4):416-22. PubMed ID: 23859335
[TBL] [Abstract][Full Text] [Related]
4. Differentiating between feline pleural effusions of cardiac and non-cardiac origin using pleural fluid NT-proBNP concentrations.
Humm K; Hezzell M; Sargent J; Connolly DJ; Boswood A
J Small Anim Pract; 2013 Dec; 54(12):656-61. PubMed ID: 24283418
[TBL] [Abstract][Full Text] [Related]
5. Utility of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) to distinguish between congestive heart failure and non-cardiac causes of acute dyspnea in cats.
Fox PR; Oyama MA; Reynolds C; Rush JE; DeFrancesco TC; Keene BW; Atkins CE; Macdonald KA; Schober KE; Bonagura JD; Stepien RL; Kellihan HB; Nguyenba TP; Lehmkuhl LB; Lefbom BK; Moise NS; Hogan DF
J Vet Cardiol; 2009 May; 11 Suppl 1():S51-61. PubMed ID: 19394287
[TBL] [Abstract][Full Text] [Related]
6. Serum and pleural fluid N-Terminal-Pro-B-Type natriuretic peptide concentrations in the differential diagnosis of pleural effusions.
Yorgancıoğlu A; Ozgen Alpaydın A; Yaman N; Taneli F; Bayturan O; Sakar Coşkun A; Celik P
Tuberk Toraks; 2011; 59(1):1-7. PubMed ID: 21554224
[TBL] [Abstract][Full Text] [Related]
7. High diagnostic accuracy of NT-proBNP for cardiac origin of pleural effusions.
Kolditz M; Halank M; Schiemanck CS; Schmeisser A; Höffken G
Eur Respir J; 2006 Jul; 28(1):144-50. PubMed ID: 16481382
[TBL] [Abstract][Full Text] [Related]
8. Cautious application of pleural N-terminal pro-B-type natriuretic peptide in diagnosis of congestive heart failure pleural effusions among critically ill patients.
Yeh JH; Huang CT; Liu CH; Ruan SY; Tsai YJ; Chien YC; Yang CY; Huang CK; Hsu CL; Kuo LC; Lee PL; Ku SC; Kuo PH; Yu CJ;
PLoS One; 2014; 9(12):e115301. PubMed ID: 25502236
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of point-of-care thoracic ultrasound and NT-proBNP for the diagnosis of congestive heart failure in cats with respiratory distress.
Ward JL; Lisciandro GR; Ware WA; Viall AK; Aona BD; Kurtz KA; Reina-Doreste Y; DeFrancesco TC
J Vet Intern Med; 2018 Sep; 32(5):1530-1540. PubMed ID: 30216579
[TBL] [Abstract][Full Text] [Related]
10. The importance of pleural fluid and serum NT-proBNP levels in differentiating pleural effusion due to heart failure from other causes of effusion.
Seyhan EC; Altin S; Cetinkaya E; Sokucu S; Gunluoglu MZ; Demir A; Korkmaz P; Issever H
Intern Med; 2009; 48(5):287-93. PubMed ID: 19252349
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the diagnostic accuracy of circulating natriuretic peptide concentrations to distinguish between cats with cardiac and non-cardiac causes of respiratory distress.
Connolly DJ; Soares Magalhaes RJ; Fuentes VL; Boswood A; Cole G; Boag A; Syme HM
J Vet Cardiol; 2009 May; 11 Suppl 1():S41-50. PubMed ID: 19394286
[TBL] [Abstract][Full Text] [Related]
12. Multicenter evaluation of plasma N-terminal probrain natriuretic peptide (NT-pro BNP) as a biochemical screening test for asymptomatic (occult) cardiomyopathy in cats.
Fox PR; Rush JE; Reynolds CA; Defrancesco TC; Keene BW; Atkins CE; Gordon SG; Schober KE; Bonagura JD; Stepien RL; Kellihan HB; Macdonald KA; Lehmkuhl LB; Nguyenba TP; Sydney Moise N; Lefbom BK; Hogan DF; Oyama MA
J Vet Intern Med; 2011; 25(5):1010-6. PubMed ID: 21985136
[TBL] [Abstract][Full Text] [Related]
13. Comparing serum and pleural fluid pro-brain natriuretic peptide (NT-proBNP) levels with pleural-to-serum albumin gradient for the identification of cardiac effusions misclassified by Light's criteria.
Porcel JM; Chorda J; Cao G; Esquerda A; Ruiz-González A; Vives M
Respirology; 2007 Sep; 12(5):654-9. PubMed ID: 17875051
[TBL] [Abstract][Full Text] [Related]
14. Multi-centered investigation of a point-of-care NT-proBNP ELISA assay to detect moderate to severe occult (pre-clinical) feline heart disease in cats referred for cardiac evaluation.
Machen MC; Oyama MA; Gordon SG; Rush JE; Achen SE; Stepien RL; Fox PR; Saunders AB; Cunningham SM; Lee PM; Kellihan HB
J Vet Cardiol; 2014 Dec; 16(4):245-55. PubMed ID: 25456274
[TBL] [Abstract][Full Text] [Related]
15. Investigation of an N-Terminal Prohormone of Brain Natriuretic Peptide Point-of-Care ELISA in Clinically Normal Cats and Cats With Cardiac Disease.
Harris AN; Beatty SS; Estrada AH; Winter B; Bohannon M; Sosa I; Hanscom J; Mainville CA; Gallagher AE
J Vet Intern Med; 2017 Jul; 31(4):994-999. PubMed ID: 28617995
[TBL] [Abstract][Full Text] [Related]
16. Utility of measuring plasma N-terminal pro-brain natriuretic peptide in detecting hypertrophic cardiomyopathy and differentiating grades of severity in cats.
Wess G; Daisenberger P; Mahling M; Hirschberger J; Hartmann K
Vet Clin Pathol; 2011 Jun; 40(2):237-44. PubMed ID: 21434959
[TBL] [Abstract][Full Text] [Related]
17. Effect of feline characteristics on plasma N-terminal-prohormone B-type natriuretic peptide concentration and comparison of a point-of-care test and an ELISA test.
Hanås S; Holst BS; Höglund K; Häggström J; Tidholm A; Ljungvall I
J Vet Intern Med; 2020 May; 34(3):1187-1197. PubMed ID: 32200578
[TBL] [Abstract][Full Text] [Related]
18. Comparison of pleural N-terminal pro-B-type natriuretic peptide, midregion pro-atrial natriuretic peptide and mid-region pro-adrenomedullin for the diagnosis of pleural effusions associated with cardiac failure.
Porcel JM; Bielsa S; Morales-Rull JL; Civit C; Cao G; Light RW; Esquerda A
Respirology; 2013 Apr; 18(3):540-5. PubMed ID: 23278975
[TBL] [Abstract][Full Text] [Related]
19. Association between Survival Time and Changes in NT-proBNP in Cats Treated for Congestive Heart Failure.
Pierce KV; Rush JE; Freeman LM; Cunningham SM; Yang VK
J Vet Intern Med; 2017 May; 31(3):678-684. PubMed ID: 28370373
[TBL] [Abstract][Full Text] [Related]
20. Clinical utility of pleural fluid NT-pro brain natriuretic peptide (NT-proBNP) in patients with pleural effusions.
Han CH; Choi JE; Chung JH
Intern Med; 2008; 47(19):1669-74. PubMed ID: 18827414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
